Search results
Results from the WOW.Com Content Network
A United Nations report also noted that India had the third largest number of people living with HIV/AIDS in the world at the end of 2013, standing at 2.1 million affected people, accounting for about 4 out of every 10 people living with HIV/AIDS. [1] The HIV/AIDS Prevention Bill (No. III), 2014 was introduced in the Rajya Sabha on 17 February ...
The study found a 39% lower HIV infection rate in women using 1% tenofovir gel compared with women using a placebo gel. In addition, tenofovir gel was shown to be safe as tested. [ 21 ] The results of the CAPRISA 004 trial provide statistically significant evidence that ARVs, topically applied to the vaginal mucosa, can offer protection against ...
Where one partner of a couple has HIV infection, consistent condom use results in rates of HIV infection for the uninfected person below 1% per year. [22] Some data support the equivalence of internal condoms to latex condoms, but the evidence is not definitive. [23] As of January 2019, condoms are available inside 30% of prisons globally. [24]
Multipurpose prevention technologies (MPTs) are a class of products designed to address at least two health issues simultaneously, often focusing on sexual and reproductive health which includes contraception, human immunodeficiency virus (HIV) prevention, other sexually transmitted infection (STI) preventions, such as genital infection by human simplex virus (HSV) infection and human ...
A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday. The ambition is to start ...
The diminished rate of new HIV infections brought about by these strategies are marked progress towards UNAIDS' 90-90-90 and 95-95-95 target to eliminate HIV/AIDS as a public health crisis by 2030. [8] However, key populations in countries in Africa, Asia, and the Middle East may still have lower access to treatment. [9]
Infections like mumps orchitis. Infections like mumps may temporarily or permanently affect testosterone by increasing inflammation in the testicles. ... HIV/AIDS. HIV and AIDS can impair ...
The discovery and development of an HIV/AIDS vaccine for the prevention of HIV infection and AIDS is a high priority of the NIAID. Through a balanced HIV program that integrates both basic research and empiric testing of candidate vaccines, NIAID supports a broad spectrum of research and development on HIV/AIDS vaccines.